EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis



DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis



Journal of Clinical Investigation 103(10): 1379-1389



Heterologous expression of the cystic fibrosis transmembrane conductance regulator (CFTR) provided evidence that the major cystic fibrosis (CF) mutation DELTAF508 leads to defective protein folding in the endoplasmic reticulum, which prevents its processing and targeting to the cell surface. In this study, we investigated endogenous CFTR expression in skin biopsies and respiratory and intestinal tissue specimens from DELTAF508 homozygous and non-CF patients, using immunohistochemical and immunoblot analyses with a panel of CFTR antibodies. CFTR expression was detected at the luminal surface of reabsorptive sweat ducts and airway submucosal glands, at the apex of ciliated cells in pseudostratified respiratory epithelia and of isolated cells of the villi of duodenum and jejunum, and within intracellular compartments of intestinal goblet cells. In DELTAF508 homozygous patients, expression of the mutant protein proved to be tissue specific. Whereas DELTAF508 CFTR was undetectable in sweat glands, the expression in the respiratory and intestinal tracts could not be distinguished from the wild-type by signal intensity or localization. The tissue-specific variation of DELTAF508 CFTR expression from null to apparently normal amounts indicates that DELTAF508 CFTR maturation can be modulated and suggests that determinants other than CFTR mislocalization should play a role in DELTAF508 CF respiratory and intestinal disease.

(PDF emailed within 0-6 h: $19.90)

Accession: 010412345

Download citation: RISBibTeXText

PMID: 10330420

DOI: 10.1172/JCI5731



Related references

Na+/H+ exchanger regulatory factor isoform 1 overexpression modulates cystic fibrosis transmembrane conductance regulator (CFTR) expression and activity in human airway 16HBE14o- cells and rescues DeltaF508 CFTR functional expression in cystic fibrosis cells. Journal of Biological Chemistry 280(49): 40925-40933, 2005

Inhibition of protein kinase CK2 closes the CFTR Cl channel, but has no effect on the cystic fibrosis mutant deltaF508-CFTR. Cellular Physiology and Biochemistry 24(5-6): 347-360, 2010

A novel identified protein, EMEP rescues misprocessing of DELTAF508 CFTR present in most patients with cystic fibrosis. Cell Structure & Function 26(5): 502, October, 2001

Morphological changes in the vas deferens and expression of the cystic fibrosis transmembrane conductance regulator (CFTR) in control, deltaF508 and knock-out CFTR mice during postnatal life. Molecular Reproduction and Development 55(2): 125-135, 2000

Calcium-pump inhibitors induce functional surface expression of DELTAF508-CFTR protein in cystic fibrosis epithelial cells. Nature Medicine 8(5): 485-492, 2002

Mild processing defect of porcine DeltaF508-CFTR suggests that DeltaF508 pigs may not develop cystic fibrosis disease. Biochemical and Biophysical Research Communications 373(1): 113-118, 2008

Expression of DeltaF508 Cystic Fibrosis Transmembrane Regulator (CFTR) Decreases Membrane Sialylation. Open Respiratory Medicine Journal 3: 79-84, 2009

CFTR 9T allele of intron 8 associated with DELTAF508 mutation in patients with cystic fibrosis. Clinical Chemistry & Laboratory Medicine 37(SPEC SUPPL ): S151, June, 1999

A novel candidate gene to rescue misprocessing of DELTAF508 CFTR present in most patients with cystic fibrosis. Molecular Biology of the Cell 11(Supplement): 419a, 2000

ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cells. Journal of Biological Chemistry 286(24): 21239-21253, 2011

Design and synthesis of a hybrid potentiator-corrector agonist of the cystic fibrosis mutant protein DeltaF508-CFTR. Bioorganic & Medicinal Chemistry Letters 20(1): 87-91, 2010

Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis. Thorax 60(1): 55-59, 2004

Sildenafil (Viagra) corrects DELTAF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis. Thorax 60(1): 55-59, 2005

Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation. Diabetes Care 30(5): 1187-1192, 2007